Abstract A series of 3-substituted 6-methoxy-1H-pyrazolo [3,4-b]quinoline derivatives was synthesized by treating 6-methoxy-1H-pyrazolo [3,4-b]quinolin-3-amine (6) with different acid anhydrides including succinic anhydride, maleic anhydride and phthalic anhydride. Also, a series of 3-hetero aryl-2-chloro-6-methoxyquinolines was prepared through 1,3-dipolar cycloaddition of different bi-nucleophiles including hydrazine hydrate, hydroxylamine hydrochloride, thiourea, guanidine hydrochloride, urea and metformin hydrochloride to the chalcone derivative 3-(2-chloro-6-methoxyquinolin-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one. Structural identifications of all products were reported and the new compounds were screened for their in vitro antimicrobial activity against Streptococcus pneumonia and Bacillus subtilis as examples for Gram-positive bacteria, Pseudomonas aeruginosa and Escherichia coli as examples for Gram-negative bacteria, and Aspergillus fumigatus, Syncephalastrum racemosum, Geotriucum candidum and Candida albicans as representative examples of fungi. The majority of tested compounds showed moderate activities against a wide range of the selected organisms. Among the tested compounds, pyrimidine derivatives 16 and 17 showed the highest antimicrobial activity against gram-positive strains while the highest activity against E. coli as example for Gram-negative strains was observed in the case of 11 and 17. Compounds 14 and 17 were found to be extremely potent against three of the selected fungal strains.
Introduction
1H-pyrazolo [3,4-b] quinolines revealed a wide range of biological activities for example as antimicrobial agents 1,2 antiviral, 3 and as amebicidal. 4 There are two main procedures for the synthesis of 1H-pyrazolo [3,4-b] quinolines (Fig. 1) . The first one starts with a preformed pyrazole, then constructing the quinoline ring during the reaction sequence. 5, 6 This can be achieved by either condensation of the appropriate orthoamino aryl ketones or aldehydes with 1H-pyrazol-5(4H)-ones 7 or by cyclization of anilines with 4-arylidenepyrazolin-5-ones. 8 The second procedure starts with a prebuilt quinoline followed by construction of a pyrazole ring during the sequence. This procedure includes reaction of 2-chloro-3-cyanoquinolines with hydrazine giving 3-amino-1H-pyrazolo [3,4-b] quinolines. 9, 10 The present work showed synthesis of three 6-methoxy-1H-pyrazolo [3,4-b] quinoline derivatives following the latter category of reaction sequence in continuation with our recent work 11 on antimicrobial quinolines. Reaction of succinic, maleic, or phthalic anhydrides with arylamines yields N-arylsuccinimide, N-arylmaleimide and Narylphthalimide respectively. 12 Among available methodologies for creation of CAC bond, Claisen-Schmidt reaction is the most powerful one for joining two aryl moieties. 13 In the current work, 3-(2-chloro-6-methoxyquinolin-3-yl)-1-(4-methoxyphenyl)prop-2-en-1-one, belonging to a,b-unsaturated ketones, was prepared following Claisen-Schmidt condensation reaction. a,b-Unsaturated ketones (Chalcones) are well known intermediates for synthesis of various heterocycles 14 like pyrimidine-2(1H)-thione, pyrimidine, 15 pyrazole, 16 isoxazole 17 and pyrimidin-2(1H)-one. In addition, literature survey revealed that many pyrazoline derivatives were reported to have antibacterial effects. 18 Pyrimidines also are of remarkable pharmaceutical importance as antitubercular. 19 Some of the newly synthesized quinolines (Fig. 2) like Bedaquiline (1) found extraordinary active against Mycobacterium tuberculosis.
20 Laquinimod (2) is an investigational quinoline derivative for treatment of multiple sclerosis (MS). 21 GlaxoSmithKline 299423 (3) is also a potent quinoline derivative against antibiotic-resistant strains as Staphylococcus aureus and Escherichia coli. 22 In view of the above mentioned facts and as a continuation of the global interest in the development of new antimicrobial agents, the main aim of this work is to synthesize a new set of antibacterial agents belonging to quinoline scaffold that cannot be recognized by bacterial resistant machineries. In this study, Glaxo-SmithKline 299423 (3) was used as lead compound with some structural modification to obtain active antimicrobial compounds.
Results and discussion

Chemistry
The new 3-Substituted-6-Methoxy-1H-pyrazolo [3,4-b] quinoline derivatives were prepared through reaction of 6-methoxy-1H-pyrazolo [3,4-b] quinolin-3-amine with acid anhydrides. The yields obtained by this method were 60% or more. Structure confirmation of pyrazolo [3,4-b] quinoline derivatives 7-9 was performed based on their spectral data (IR, 1 H NMR, and MS). The IR spectra of these compounds showed the characteristic C‚O amide absorption bands of amide at the range of 1660-1670 cm À1 while NH stretching bands were observed in the range of 3260-3270 cm
À1
.
1 H NMR spectra of these amides are found characterized by the presence of D 2 O exchangeable singlet of the NH proton at d 12.8-13.8 in addition to another singlet of three protons of methoxy group at 3.8 ppm. In the present study, chalcone 10 was prepared through the reaction of compound 4 with pmethoxyacetophenone in the presence of alcoholic NaOH. The reaction occurred by ratio (1:1) to form chalcone which crystallized from ethanol, the structure of compound 10 was established on the basis of its elemental and spectral data. The IR spectrum of compound 10 was characterized by a strong absorption band of C‚O which appeared at low absorption value because of extended conjugation with the double bond. The absolute geometry of the a,b-unsaturated carbonyl linker was assigned to be in trans form based on the coupling constant of alkene protons. In more details, the 1 H NMR spectrum of chalcone 10 showed two doublets, each equivalent to one proton. Both have the same coupling constant value of 15.0 Hz, which confirms the E-configuration. Additionally, the 1 H NMR spectrum of compound 10 displayed two more doublets, each of two protons with a coupling constant value of 9.0 Hz which is attributed to the pdisubstituted phenyl ring. Fig. 3 provides the proposed mechanism for the formation of compound 10. In this work, seven different 1,3-dipolar cyclo-addition reactions have been achieved. Namely, chalcone 10 was allowed to react with hydrazine hydrate, hydroxylamine hydrochloride, thiourea, guanidine hydrochloride, urea, biguanide metformin hydrochloride, and S-methyisothiourea. In general, all reactions proceeded smoothly and final products were obtained in relatively good yields as detailed in the experimental part.
Scheme 1 shows the synthetic pathway of the target compounds 7-9 through reaction of 6-Methoxy-1H-pyrazolo [3,4-b] quinoline-3-amine (6) with three different acid anhydrides.
Structures of these amides were confirmed based on spectral data and elemental analyses. The IR spectra of these compounds showed the characteristic C‚O stretching bands at the range of 1666-1669 cm
. In addition, the 1 H NMR spectra of the same derivatives showed singlet signals corresponding to NH protons at d 12.8-13.8 ppm. Structures of the 3-heteroaryl-2-chloro-6-methoxyquinolines derivatives 11-17 (Scheme 2) were confirmed by the disappearance of the two doublets with high coupling constant of the alkene protons in the starting chalcone at d 8.1 and 7.9 that confirm the cyclization reactions. In addition, other additional characteristic new signals for each new derivative as shown in detail in the experimental part. In the 1 H NMR spectra of compounds 11 and 12, the CH 2 ACH fragments in pyrazoline and isoxazoline rings respectively showed the characteristic pattern of ABX system. CH 2 ACH fragment of pyrazoline ring in compound 11 showed three doublet of doublets at chemical shifts 5.1, 3.6 and 2.9 while that of isoxazoinle in compound 12 showed these doublet of doublets at d 6.0, 4.0 and 2.9.
Biological evaluation
All of the newly synthesized derivatives were evaluated as antimicrobial against two Gram-positive and two Gramnegative bacteria as well as many fungal strains. All of the test compounds showed promising activities as antimicrobial. Agar diffusion method 23, 24 was carried out to determine the in vitro antibacterial activity of the newly synthesized derivatives. In this work, two Gram-positive organisms (Streptococcus pneumoniae, Bacillus subtilis) and two Gram-negative organisms (Pseudomonas aeruginosa, and E. coli) were used to investigate the antibacterial activity.
Experimental
General
All melting points were determined by open capillary using Gallenkamp melting point apparatus and are uncorrected. The IR spectra were recorded on potassium bromide disks on a Pye Unicam SP 3300 spectrophotometer.
1 H NMR spectra were recorded on Gemini 300 MHz using TMS as an inter- Figure 3 Proposed mechanism for formation of compound 10.
Scheme 1 Synthetic protocol of compounds 7-9.
Synthesis, characterization and antimicrobial evaluation of some novel quinoline derivativesnal standard. All chemical shifts are reported in ppm downfield from TMS. Mass spectra were recorded on a Shimadzu GCMS-QP 1000 EX mass spectrometer operating at 70 eV. Elemental analyses were carried out at the Regional Center for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt. Progress of the reactions was monitored by TLC sheets precoated with UV fluorescent silica gel Merck 60 F254 plates and were visualized using UV lamp and n-hexane: ethyl acetate 9: 1 as mobile phase. Starting materials were purchased from Aldrich Chemical Company and used without further purification. Compounds 4 and 5 were prepared according to reported procedures. 25, 26 6-Methoxy-1H-pyrazolo [3,4-b] quinoline-3-amine (6) was prepared according to Jorda et al. 27 procedure. For synthesis of the new derivatives, Schemes 1 and 2 were adopted.
A mixture of compound 6 (2.14 g, 0.01 mol) and Succinic anhydride (1 g, 0.01 mol) were refluxed in acetic acid (50 ml) for 4 h, the reaction mixture was filtered off while hot and the solvent was evaporated, the solid separated was filtered and recrystallized from ethanol. 
A mixture of compound 6 (2.14 g, .01 mol) and maleic anhydride (0.98 g, 0.01 mole) was refluxed in acetic acid (50 ml) for 4 h, the reaction mixture was filtered off while hot and the solvent was evaporated, the solid separated was filtered and recrystallized from ethanol to afford the titled compound as a dark red solid. 
A mixture of compound 6 (2.14 g, .01 mol) and phthalic anhydride (1.48 g, .01 mol) was refluxed in acetic acid (50 ml) for 4 h, the reaction mixture was filtered off while hot and the solvent was removed under reduced pressure, the solid separated was filtered and recrystallized from ethanol to afford a brown solid. Yield: 70%; m.p. 290°C. IR (KBr) cm À1 : 3261 (NAH), 3071 (CAH aromatic), 2900 (CAH aliphatic), 1666 (C‚O). To a stirred and ice-cooled aqueous solution of sodium hydroxide (10 mmole, 50% w/w) and absolute ethanol (12.5 ml), 4-methoxyacetophenone (1.5 g, 10 mmole) was added followed by 2-chloro-6-methoxyquinoline-3-carbalde hyde (4) (2.2 g, 1 mmole). The reaction mixture was vigorously stirred for 3 h while the temperature was maintained below 25°C till the reaction mixture became thick. The reaction mixture was left in the refrigerator overnight. The formed precipitate was filtered off under vacuum and washed with copious amount of water until the filtrates became neutral to litmus paper, washed with ice-cold ethanol (20 ml), and finally recrys- 
2-Chloro-6-methoxy-3-[3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-5-yl]quinoline (11)
A mixture of chalcone 10 (3.53 g, 10 mmole) and hydrazine hydrate (1 ml, 20 mmole) was stirred in ethanol (20 ml) and heated at reflux for 7 h. After completion of the reaction the mixture was concentrated by evaporating out the solvent under reduced pressure, and then poured onto ice water. The obtained precipitate was filtered off, washed by water and recrystallized from ethanol to afford compound 11 as white needles. Yield: 60%; m.p. 114°C. IR (KBr) cm 
General procedure for synthesis of 3-heteroaryl-2-chloro-6-methoxyquinoline derivatives 12-17
A mixture of chalcone 10 (3.53 g, 10 mmole) and the appropriate bi-nucleophile (10 mmole) was stirred in ethanol (20 ml), and then sodium hydroxide (0.8 g, 20 mmole) was added. The reaction mixture was heated under reflux for 7 h, and then the solvent was evaporated under reduced pressure and poured into ice water. The obtained precipitate was filtered off, washed with copious amount of water and recrystallized from ethanol to afford the corresponding 3-heteroaryl-2-chloro-6-methoxyquinoline derivative 12-17. 
Antimicrobial evaluation
All the newly synthesized compounds were screened for their antifungal activity against Aspergillus fumigatus, Syncephalastrum racemosum, Geotriucum candidum and Candida albicans by poisoned food technique. 28 Bacterial and fungal strains were procured from Regional Center for Mycology and Biotechnology Laboratory, Cairo, Egypt. Ampicillin, Gentamicin and Amphotericin B were used as standards for antibacterial and antifungal studies respectively. The inhibition zones of bacteria were recorded after 24 h by visual observations while that of fungi after 72-96 h of incubation. Results of antimicrobial studies and the activity percent for each compound compared with the reference standard have been presented in Tables 1 and 2 and Charts 1-3. Screening procedure: The bacterial strain was uniformly spread using a sterile cotton swab on a sterile Petri dish MH agar. 1 mg/mL for each test compound was added to wells (7 mm diameter holes cut in the agar gel, 20 mm apart from one another). The systems were incubated for 24 h at 36°C ± 1°C, under aerobic conditions. After incubation, confluent bacterial growth was observed. Inhibition of the bacterial growth was measured in mm and compared to that of reference compounds. * Ampicellin and Gentamicin were taken as standards for anti Gram-positive and anti Gram-negative microbes respectively.
Chart 1 Antifungal activities of compounds 7-17.
Chart 2 Antimicrobial activities of compounds 7-17 against Gram-positive organisms.
Conclusion
From Tables 1 and 2 and Charts 1-3, it is clear that, the pyrimidine derivatives 16 and 17 showed the highest antimicrobial activity against Gram-positive bacterial strains while the highest activity against E. coli as example of Gram-negative strains was observed in the case of compounds 11 and 17 of which, 17 found more active than gentamicin. Almost all of synthesized compounds gave moderate to low efficacy against B. subtilis except compounds 11 and 16 which gave good activity with 72% and 76% relative to standard respectively. With the exception of compound 9, all compounds showed promising activities against three of the selected fungal strains of which, compound 14 and 17 were found extremely potent. On the other hand, no activity was found against either P. aeruginosa or C. albicans by any of the tested compounds.
